Market Overview:
The global over-the-counter (OTC) pain relievers market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of chronic pain, rising consumer awareness about OTC pain relief products, and the growing demand for convenient and easy-to-use analgesics. The nonsteroidal antiinflammatory drugs (NSAIDs) segment is expected to dominate the global OTC pain relievers market during the forecast period, owing to their high efficacy in reducing inflammation and providing relief from various types of pain. The local anaesthetics segment is projected to grow at a higher CAGR than other segments during the forecast period, as these products are increasingly being used for treating chronic conditions such as dental caries and postoperative dental pains. Geographically, North America dominates the global OTC pain relievers market due to factors such as high per capita spending on healthcare, well-developed healthcare infrastructure, and rising consumer awareness about available treatment options for various types of chronicpain.
 Pain Relievers Industry Outlook.svg)
Product Definition:
A pain reliever that can be bought without a prescription. Over-the-counter pain relievers are used to relieve pain from headaches, muscle aches, toothaches, menstrual cramps, arthritis, or other types of pain.
Non-Steroidal Anti-Inflammatory Drugs:
Non-steroidal anti-inflammatory drugs (NSAIDs) are used to reduce the inflammation associated with a number of chronic conditions. The most common uses include pain management and fever reduction, although they are also used for heart disease, cancer and other inflammatory diseases.
Local Anaesthetics:
Local Anaesthetics are also known as blocks or injections. They are used to reduce pain and they work on the central nervous system (CNS). It is one of the most commonly used medicines in pain relievers market. The OTC analgesic market is expected to show significant growth over the forecast period owing to increasing demand for non-prescription drugs, growing awareness among consumers regarding self-medication, and rising healthcare costs across various regions.
Application Insights:
The application segment includes hospital pharmacies, retail pharmacies, and online pharmacies. The online pharmacy segment is anticipated to register the highest CAGR over the forecast period owing to various benefits offered including 24*7 service availability, convenience of payment options through internet banking/credit cards etc., and ability to order repeat medicines with a few clicks.
The pain relievers available in OTC form are aspirin (acetylsalicylic acid), paracetamol ( acetaminophen) and non-steroidal anti-inflammatory drugs (NSAIDs). According to WHO estimates, around 1 in 5 adults suffer from chronic pains every year; globally these pains affect around 642 million people. Aspirin is one of the most widely used medicines for pain management as it works by reducing inflammation without causing any harm to body organs or systems.
Regional Analysis:
North America dominated the global over-the counter (OTC) pain relievers market in 2017. The presence of a large number of players coupled with high healthcare expenditure and awareness regarding alternative treatment options are some factors driving the growth. In addition, favorable reimbursement policies for patients are expected to propel demand during the forecast period.
Asia Pacific is expected to witness lucrative growth over the forecast period owing to increasing consumer spending on medicines, rising prevalence of chronic diseases such as arthritis and back pain, growing awareness about OTC products among consumers, and improving economic conditions in emerging countries such as China & India.
Growth Factors:
- Increasing incidence of chronic pain: The global prevalence of chronic pain is estimated to be around 20%. This number is expected to grow as the population ages, thereby increasing the demand for OTC pain relievers.
- Rising awareness about the benefits of over-the-counter analgesics: There is a growing awareness among consumers about the benefits of over-the-counter analgesics, which is driving their demand.
- Availability of a wide range of products: A large number of players are offering a wide range of OTC pain relief products, catering to different needs and preferences. This has helped in widening the consumer base for these products.
- Growing focus on innovation and new product launches: Players in this market are focusing on innovation and launching new products in order to stay ahead competition and tap into unexplored segments/niches.
Scope Of The Report
Report Attributes
Report Details
Report Title
Over-The-Counter (OTC) Pain Relievers Market Research Report
By Type
Non-Steroidal Anti-Inflammatory Drugs, Local Anaesthetics, Acetaminophen
By Application
Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
By Companies
Pfizer, Johnson and Johnson, Bayer, GlaxoSmithKline, Taisho Pharmaceutical, Teva Pharmaceutical, Merck, Cardinal Health, Sanofi, Sun Pharmaceutical
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
245
Number of Tables & Figures
172
Customization Available
Yes, the report can be customized as per your need.
Global Over-The-Counter (OTC) Pain Relievers Market Report Segments:
The global Over-The-Counter (OTC) Pain Relievers market is segmented on the basis of:
Types
Non-Steroidal Anti-Inflammatory Drugs, Local Anaesthetics, Acetaminophen
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Pfizer
- Johnson and Johnson
- Bayer
- GlaxoSmithKline
- Taisho Pharmaceutical
- Teva Pharmaceutical
- Merck
- Cardinal Health
- Sanofi
- Sun Pharmaceutical
 Pain Relievers Market Overview.svg)
Highlights of The Over-The-Counter (OTC) Pain Relievers Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Non-Steroidal Anti-Inflammatory Drugs
- Local Anaesthetics
- Acetaminophen
- By Application:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Over-The-Counter (OTC) Pain Relievers Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
 Pain Relievers Market Statistics.svg)
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
OTC pain relievers are medications that are not typically prescribed by a doctor, but can be purchased over the counter. OTC pain relievers can include ibuprofen, acetaminophen (Tylenol), and naproxen (Aleve).
Some of the major companies in the over-the-counter (otc) pain relievers market are Pfizer, Johnson and Johnson, Bayer, GlaxoSmithKline, Taisho Pharmaceutical, Teva Pharmaceutical, Merck, Cardinal Health, Sanofi, Sun Pharmaceutical.
The over-the-counter (otc) pain relievers market is expected to register a CAGR of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Over-The-Counter (OTC) Pain Relievers Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Over-The-Counter (OTC) Pain Relievers Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Over-The-Counter (OTC) Pain Relievers Market - Supply Chain
4.5. Global Over-The-Counter (OTC) Pain Relievers Market Forecast
4.5.1. Over-The-Counter (OTC) Pain Relievers Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Over-The-Counter (OTC) Pain Relievers Market Size (000 Units) and Y-o-Y Growth
4.5.3. Over-The-Counter (OTC) Pain Relievers Market Absolute $ Opportunity
5. Global Over-The-Counter (OTC) Pain Relievers Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Over-The-Counter (OTC) Pain Relievers Market Size and Volume Forecast by Type
5.3.1. Non-Steroidal Anti-Inflammatory Drugs
5.3.2. Local Anaesthetics
5.3.3. Acetaminophen
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Over-The-Counter (OTC) Pain Relievers Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Over-The-Counter (OTC) Pain Relievers Market Size and Volume Forecast by Application
6.3.1. Hospital Pharmacies
6.3.2. Retail Pharmacies
6.3.3. Online Pharmacies
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Over-The-Counter (OTC) Pain Relievers Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Over-The-Counter (OTC) Pain Relievers Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Over-The-Counter (OTC) Pain Relievers Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Over-The-Counter (OTC) Pain Relievers Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Over-The-Counter (OTC) Pain Relievers Demand Share Forecast, 2019-2026
9. North America Over-The-Counter (OTC) Pain Relievers Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Over-The-Counter (OTC) Pain Relievers Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Over-The-Counter (OTC) Pain Relievers Market Size and Volume Forecast by Application
9.4.1. Hospital Pharmacies
9.4.2. Retail Pharmacies
9.4.3. Online Pharmacies
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Over-The-Counter (OTC) Pain Relievers Market Size and Volume Forecast by Type
9.7.1. Non-Steroidal Anti-Inflammatory Drugs
9.7.2. Local Anaesthetics
9.7.3. Acetaminophen
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Over-The-Counter (OTC) Pain Relievers Demand Share Forecast, 2019-2026
10. Latin America Over-The-Counter (OTC) Pain Relievers Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Over-The-Counter (OTC) Pain Relievers Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Over-The-Counter (OTC) Pain Relievers Market Size and Volume Forecast by Application
10.4.1. Hospital Pharmacies
10.4.2. Retail Pharmacies
10.4.3. Online Pharmacies
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Over-The-Counter (OTC) Pain Relievers Market Size and Volume Forecast by Type
10.7.1. Non-Steroidal Anti-Inflammatory Drugs
10.7.2. Local Anaesthetics
10.7.3. Acetaminophen
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Over-The-Counter (OTC) Pain Relievers Demand Share Forecast, 2019-2026
11. Europe Over-The-Counter (OTC) Pain Relievers Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Over-The-Counter (OTC) Pain Relievers Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Over-The-Counter (OTC) Pain Relievers Market Size and Volume Forecast by Application
11.4.1. Hospital Pharmacies
11.4.2. Retail Pharmacies
11.4.3. Online Pharmacies
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Over-The-Counter (OTC) Pain Relievers Market Size and Volume Forecast by Type
11.7.1 Non-Steroidal Anti-Inflammatory Drugs
11.7.2. Local Anaesthetics
11.7.3. Acetaminophen
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Over-The-Counter (OTC) Pain Relievers Demand Share, 2019-2026
12. Asia Pacific Over-The-Counter (OTC) Pain Relievers Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Over-The-Counter (OTC) Pain Relievers Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Over-The-Counter (OTC) Pain Relievers Market Size and Volume Forecast by Application
12.4.1. Hospital Pharmacies
12.4.2. Retail Pharmacies
12.4.3. Online Pharmacies
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Over-The-Counter (OTC) Pain Relievers Market Size and Volume Forecast by Type
12.7.1. Non-Steroidal Anti-Inflammatory Drugs
12.7.2. Local Anaesthetics
12.7.3. Acetaminophen
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Over-The-Counter (OTC) Pain Relievers Demand Share, 2019-2026
13. Middle East & Africa Over-The-Counter (OTC) Pain Relievers Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Over-The-Counter (OTC) Pain Relievers Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Over-The-Counter (OTC) Pain Relievers Market Size and Volume Forecast by Application
13.4.1. Hospital Pharmacies
13.4.2. Retail Pharmacies
13.4.3. Online Pharmacies
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Over-The-Counter (OTC) Pain Relievers Market Size and Volume Forecast by Type
13.7.1. Non-Steroidal Anti-Inflammatory Drugs
13.7.2. Local Anaesthetics
13.7.3. Acetaminophen
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Over-The-Counter (OTC) Pain Relievers Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Over-The-Counter (OTC) Pain Relievers Market: Market Share Analysis
14.2. Over-The-Counter (OTC) Pain Relievers Distributors and Customers
14.3. Over-The-Counter (OTC) Pain Relievers Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Pfizer
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Johnson and Johnson
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Bayer
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. GlaxoSmithKline
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Taisho Pharmaceutical
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Teva Pharmaceutical
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Merck
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Cardinal Health
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Sanofi
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Sun Pharmaceutical
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
